GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a substantial innovation in how we approach type 2 diabetes . These new therapies work by mimicking the body’s inherent GLP-1 substance , https://mariyahgaqy929881.blogsvirals.com/40610902/glp-1-a-major-approach-in-diabetes-care